Patents matching “targeted”

US 9737560

Process for preparation of a humic substance based gel for targeted external application

BlackBalm, LLC · Granted Aug 22, 2017 · Expires Aug 17, 2037

US 9731011

Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9730993

Engineered anthrax lethal toxin for targeted delivery

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9642805

Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy

Northwestern University · Granted May 9, 2017 · Expires May 4, 2037

US 9636374

pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics

Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

US 9629899

Targeted cargo protein combination therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

US 9631186

Methods and compositions for targeted single-stranded cleavage and targeted integration

Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

US 9610358

Targeted pharmacological chaperones

Marker Gene Technologies, Inc · Granted Apr 4, 2017 · Expires Mar 30, 2037

US 9592304

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9566295

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9566355

Bacteria-targeted magnetic resonance contrast agents

Northwestern University · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9534033

Targeted interferons demonstrating potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Jan 3, 2017 · Expires Dec 29, 2036

US 9517275

Targeted therapy for the prevention of restenosis in the cardiovascular system

Northwestern University · Granted Dec 13, 2016 · Expires Dec 8, 2036

US 9504745

Compositions and methods for cancer treatment using targeted carbon nanotubes

The Board of Regents of the University of Oklahoma · Granted Nov 29, 2016 · Expires Nov 24, 2036

US 9415110

Method and compositions for targeted drug delivery to the lower GI tract

Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 16, 2016 · Expires Aug 11, 2036

US 9394369

Luminescent porous silicon nanoparticles for targeted delivery and immunization

The Regents of the University of California · Granted Jul 19, 2016 · Expires Jul 14, 2036

US 9376480

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

US 9351490

Selectively targeted antimicrobial peptides and the use thereof

The Regents of the University of California · Granted May 31, 2016 · Expires May 26, 2036

US 9345775

Compositions for targeted delivery of siRNA

Arrowhead Madison, Inc. · Granted May 24, 2016 · Expires May 19, 2036

US 9345781

Targeted dendrimer-drug conjugates

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 24, 2016 · Expires May 19, 2036

US 9289513

Targeted cytokine for treatment of musculoskeletal diseases

OPTION PHARMACEUTICALS, LLC · Granted Mar 22, 2016 · Expires Mar 17, 2036

US 9289451

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Mar 22, 2016 · Expires Mar 17, 2036

US 9267154

Targeted integration into the PPP1R12C locus

Sangamo Biosciences, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

US 9260726

Targeted integration and expression on exogenous nucleic acid sequences

Sangamo Biosciences, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036